National Brain Tumor Society commends the unanimous adoption by the U.S. Senate of a bipartisan resolution officially designating Wednesday, July 15, 2026, as the eighth annual Glioblastoma Awareness Day in the United States. This resolution reflects the continued commitment of lawmakers to raise public awareness of this highly aggressive and deadly form of brain cancer and honors those who have been impacted by glioblastoma.
This year’s resolution in the Senate (S.Res.786) was once again led by Sen. Lindsey Graham [R-SC] who was joined by Sens. Mark Kelly [D-AZ], John Barrasso [R-WY], Tim Scott [R-SC], Chris Van Hollen [D-MD], Edward J. Markey [D-MA], Elizabeth Warren [D-MA], Christopher A. Coons [D-DE], Ruben Gallego [D-AZ], and Jeanne Shaheen [D-NH].
A companion measure in the House of Representatives (H.Res. 1270) was again led by Reps. Roger Williams [R-TX], Jake Auchincloss [D-MA-4], Brian J. Mast, [R-FL-21] and Janice D. Schakowsky [D-IL-9], along with Reps. Paul Tonko [D-NY-20], Michael T. McCaul [R-TX-10], Brian K. Fitzpatrick [R-PA-1], Michael K. Simpson [R-ID-2], Michael Lawler [R-NY-17], Don Bacon [R-NE-2], Maria Elvira Salazar [R-FL-27], Mike Quigley [D-IL-5], Salud O. Carbajal [D-CA-24], Jamie Raskin [D-MD-8], Zoe Lofgren [D-CA-18], Suzanne Bonamici [D-OR-1], James P. McGovern [D-MA-2], Debbie Dingell [D-MI-6], Donald G. Davis [D-NC-1], Doris O. Matsui [D-CA-7], Lori Trahan [D-MA-3], Chris Pappas [D-NH-1], Josh Riley [D-NY-19], J. French Hill [R-AR-2], Josh Gottheimer [D-NJ-5], Darren Soto [D-FL-9], and Jonathan L. Jackson [D-IL-1]. Under its rules, the House does not vote on commemorative resolutions.
The following is a statement from David F. Arons, president and chief executive officer of the National Brain Tumor Society (NBTS):
“On the eighth annual Glioblastoma Awareness Day, July 15, 2026, we will gather as a community to amplify the voices, experiences, and urgent needs of everyone living with glioblastoma, one of the most complex, treatment-resistant, and deadliest types of cancer. We give our thanks to the leaders in the House and Senate who made the bipartisan resolutions possible, officially designating July 15, 2026 as Glioblastoma Awareness Day.
“Thanks to rapidly evolving science, emerging technologies, a dedicated research community, inspired philanthropy and investors, critical government funding, spirited advocacy and the generosity of patients and their caregivers who participate in clinical trials, there is more hope than ever before for better treatments and a cure.
“For these hopes to be realized, though, we must keep the momentum going. And we are doing just that, as we champion the Bolstering Research And Innovation Now (BRAIN) Act (H.R.2767/S.1330), a landmark, bipartisan piece of legislation developed specifically to address the unique needs of Americans living with brain tumors like glioblastoma, as well as the researchers and clinicians advancing their care. The BRAIN Act takes a comprehensive approach to improving outcomes, from basic scientific research and early-phase drug development to clinical trials, diagnostic innovation, treatment planning, and quality-of-life support. Its ongoing presence in Congress is a clear signal that glioblastoma and other brain tumors are receiving the national attention they urgently deserve.
“As the largest patient advocacy non-profit in the United States dedicated to the brain tumor community, NBTS is deeply grateful to the bipartisan group of Senators and Representatives who continue to lead the charge on behalf of the brain tumor community. And these congressional sponsorships are a direct result of the incredible dedication of more than 350 advocates who met with their lawmakers to ask for their support during our annual Head to the Hill fly-in this past May. This partnership between the people and their members of congress is critical as we continue to advocate for change for this community.
“On July 15, we ask all Americans to join us in honoring Glioblastoma Awareness Day. Visit braintumor.org and GBMawarenessDay.org to learn more, take action, and be part of the movement to defeat brain tumors, including GBM, once and for all.”
Read the full text of the Senate resolution here.
The full House resolution can be found here.
About Glioblastoma
Glioblastoma is the most common malignant (cancerous) brain tumor, accounting for approximately half of all primary malignant brain tumors. These tumors are also the most aggressive, complex, difficult to treat, and deadly type of brain tumor. It’s estimated that more than 14,000 new cases of glioblastoma will be diagnosed in the United States in 2026, and that about 10,000 individuals in the United States will succumb to their disease this year. The five-year survival rate for glioblastoma patients is only 7 percent, and the median length of survival is only 8 months. These rates have changed little during the past 30 years.
